DK

Digamber Kumar Gupta

Director Director DIN 07157541
DIN 07157541 First appointment Mar 2015 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2015
Shareholding value •••• Premium profile

About Digamber Kumar Gupta

Data last updated:

Digamber Kumar Gupta was a Director at Cetyl Pharma Private Limited (2015–2017) and Director at Nectrine Chemicals India Private Limited (2015–2021). The companies operate in Chemicals and Materials.

DIN 07157541
Primary Designation Director
Industry Chemicals and Materials
First Appointment 15 Mar 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cetyl Pharma Private Limited U65990MH1992PTC068903
Director15 Mar 20151992₹1.79 Cr (FY 2025)Active
Director10 Jul 20152004₹1.47 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cetyl Pharma Private Limited
Nectrine Chemicals India Private Limited
Premium access

Shareholding and investment profile for Digamber Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digamber Kumar Gupta

Digamber Kumar Gupta was first appointed on 15 Mar 2015 as Director at Cetyl Pharma Private Limited.

Digamber Kumar Gupta held 2 earlier board appointments: Cetyl Pharma Private Limited (Director, 15 Mar 2015 to 13 Nov 2017); Nectrine Chemicals India Private Limited (Director, 10 Jul 2015 to 18 May 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available